Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AstraZeneca plc (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AZN
Nasdaq
2834
https://www.astrazeneca.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AstraZeneca plc (ADR)
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
- Mar 28th, 2024 1:50 pm
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
- Mar 27th, 2024 4:42 pm
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
- Mar 26th, 2024 9:50 pm
AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
- Mar 26th, 2024 1:56 pm
UPDATE 1-China to speed up 'new productive forces', vice president says
- Mar 26th, 2024 10:18 am
Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know
- Mar 25th, 2024 10:00 pm
31 European Countries That Offer Citizenship by Descent
- Mar 25th, 2024 6:52 pm
German industry sceptical of China's vow to treat foreign firms equally
- Mar 25th, 2024 1:48 pm
Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
- Mar 25th, 2024 1:09 pm
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
- Mar 25th, 2024 11:00 am
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
- Mar 22nd, 2024 3:59 pm
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
- Mar 22nd, 2024 3:33 pm
Ionis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?
- Mar 22nd, 2024 3:30 pm
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
- Mar 21st, 2024 4:29 pm
UPDATE 2-Merck combination treatment for lung cancer fails late-stage study
- Mar 21st, 2024 11:17 am
UPDATE 1-GSK to cap out-of-pocket inhaler costs in US
- Mar 20th, 2024 9:58 pm
15 Countries with the Highest Life Expectancy in Africa
- Mar 20th, 2024 9:51 pm
3 Stagnating Blue-Chip Stocks Ready to Awaken and Soar
- Mar 20th, 2024 7:41 pm
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
- Mar 20th, 2024 5:21 pm
AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
- Mar 20th, 2024 3:49 pm
Scroll